| 產(chǎn)品編號 | bs-0094R-APC |
| 英文名稱 | Rabbit Anti-Alpha-1-Antichymotrypsin/APC Conjugated antibody |
| 中文名稱 | APC標記的α-1抗胰糜蛋白酶/SERPINA3抗體 |
| 別 名 | Alpha 1-Antichymotrypsin; AACT-Alpha 1; AACT Alpha 1; SERPINA3; AACT; A1ACT; ACT; Alpha 1 Antichymotrypsin 1; Alpha 1 Antichymotrypsin 2; Alpha 1 Antichymotrypsin 3; Alpha 1 Antitrypsin Deficiency; Anti Elastase; Antichymotrypsin; Cell growth inhibiting gene 24/25 protein; Clade A (Alpha 1 Antiproteinase Antitrypsin); GIG24; GIG25; Growth inhibiting protein 24; Growth inhibiting protein 25; MGC88254; PI1; Protease Inhibitor 1; Serine (or Cysteine) Proteinase Inhibitor; Serine (or cysteine) proteinase inhibitor clade A (alpha 1 antiproteinase, antitrypsin) member 3; Serine (or cysteine) proteinase inhibitor clade A member 3; Serine proteinase inhibitor clade A member 3; Serpin peptidase inhibitor clade A (alpha 1 antiproteinase antitrypsin) member 3; SERPINA1; SERPINA2; SERPINA3; Serpin A3; Alpha-1-antichymotrypsin His-Pro-less; AACT_HUMAN. |
| 規(guī)格價格 | 100ul/2980元 購買 大包裝/詢價 |
| 說 明 書 | 100ul |
| 研究領(lǐng)域 | 心血管 細胞生物 神經(jīng)生物學 糖尿病 泛素 Alzheimer's |
| 抗體來源 | Rabbit |
| 克隆類型 | Polyclonal |
| 交叉反應 | Mouse, Rat, (predicted: Human, ) |
| 產(chǎn)品應用 | IF=1:50-200
not yet tested in other applications. optimal dilutions/concentrations should be determined by the end user. |
| 分 子 量 | 45kDa |
| 性 狀 | Lyophilized or Liquid |
| 濃 度 | 1mg/ml |
| 免 疫 原 | KLH conjugated synthetic peptide derived from human AACT-Alpha1 N-terminus |
| 亞 型 | IgG |
| 純化方法 | affinity purified by Protein A |
| 儲 存 液 | 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol. |
| 保存條件 | Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C. |
| 產(chǎn)品介紹 |
background: Alpha 1-Antichymotrypsin, a member of the serine proteinase inhibitor (serpin) family, inhibits neutrophil proteinase cathepsin G and mast cell chymases, and protects the lower respiratory tract from damage by proteolytic enzymes. It contains a reactive centre loop, which interacts with cognate proteinases, resulting in loop cleavage and a major conformational change. Recently, alpha 1-antichymotrypsin has been identified as a major constituent of the neurofibrillary plaques associated with Alzheimers disease, and in vitro studies have shown that it enhances the rate of amyloid-fibril formation. These observations and recent genetic evidence suggest that alpha 1-antichymotrypsin is important in the pathogenesis of Alzheimers disease. Function: Although its physiological function is unclear, it can inhibit neutrophil cathepsin G and mast cell chymase, both of which can convert angiotensin-1 to the active angiotensin-2. Subunit: Interacts with DNAJC1. Subcellular Location: Secreted. Tissue Specificity: Plasma. Synthesized in the liver. Like the related alpha-1-antitrypsin, its concentration increases in the acute phase of inflammation or infection. Found in the amyloid plaques from the hippocampus of Alzheimer disease brains. Similarity: Belongs to the serpin family. Database links: Entrez Gene: 12 Human Omim: 107280 Human SwissProt: P01011 Human Unigene: 534293 Human Unigene: 710488 Human Important Note: This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications. AACT是由神經(jīng)膠質(zhì)細胞分泌并參與淀粉樣纖維生成和沉積的一種色氨酸蛋白酶抑制劑,被認為是Aβ肽的假性底物，與Aβ肽具有很高的親合性，可促進Aβ肽的纖維化以生成淀粉樣沉積。 ApoE作為AD的另一種病理伴隨性物質(zhì)，也可識別并與Aβ肽相結(jié)合，促進Aβ肽沉積生成淀粉樣老年斑塊。由于AACT和ApoE在AD發(fā)病中具有共同的作用途徑，因此探討其相互作用可能是AD治療中一個新的途徑。 AACT是一種絲氨酸蛋白酶抑制劑，可以中和糜蛋白酶等酶活性的蛋白酶，存在于大多數(shù)的組織細胞、巨噬細胞以及多種胃腸道和肺部腫瘤中，但多形核白細胞中無此物質(zhì)，它可以作為組織細胞瘤和良性/惡性纖維組織細胞瘤的標志。此抗體與人的AACT反應，主要用于惡性纖維組織細胞瘤等惡性腫瘤的診斷,也可用于胃癌﹑肺癌、腎癌等腫瘤的研究。 |
| 1、抗體溶解方法 | |
| 2、抗體修復方式 | |
| 3、常用試劑的配制 | |
| 4、免疫組化操作步驟 | |
| 5、免疫組化問題解答 | |
| 6、Western Blotting 操作步驟 | |
| 7、Western Blotting 問題解答 | |
| 8、關(guān)于肽鏈的設計 | |
| 9、多肽的溶解與保存 | |
| 10、酶標抗體效價測定程序 | |
